DK2062573T3 - Misbrugsresistent opioid indeholdende transdermale systemer - Google Patents

Misbrugsresistent opioid indeholdende transdermale systemer

Info

Publication number
DK2062573T3
DK2062573T3 DK08020810.1T DK08020810T DK2062573T3 DK 2062573 T3 DK2062573 T3 DK 2062573T3 DK 08020810 T DK08020810 T DK 08020810T DK 2062573 T3 DK2062573 T3 DK 2062573T3
Authority
DK
Denmark
Prior art keywords
abuse
transdermal systems
containing transdermal
dosage form
opioid containing
Prior art date
Application number
DK08020810.1T
Other languages
English (en)
Inventor
Lino Tavares
Bruce E Reidenberg
Richard S Sackler
Curtis Wright
Benjamin Oshlack
James P Cassidy
Anthony E Carpanzano
Rampurna Prasad Gullapalli
Ihor Shevchuk
Mark A Alfonso
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK2062573T3 publication Critical patent/DK2062573T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE
    • B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
    • B09B3/0075—Disposal of medical waste
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE
    • B09B2101/00—Type of solid waste
    • B09B2101/65—Medical waste
    • B09B2101/68—Transdermal patches
DK08020810.1T 2001-05-01 2002-04-30 Misbrugsresistent opioid indeholdende transdermale systemer DK2062573T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28787501P 2001-05-01 2001-05-01
US29253701P 2001-05-22 2001-05-22
EP02731653A EP1397095B1 (en) 2001-05-01 2002-04-30 Abuse resistant opioid containing transdermal systems

Publications (1)

Publication Number Publication Date
DK2062573T3 true DK2062573T3 (da) 2012-01-30

Family

ID=26964697

Family Applications (3)

Application Number Title Priority Date Filing Date
DK10009943.1T DK2316439T3 (da) 2001-05-01 2002-04-30 Misbrugssikrede transdermale systemer, der indeholder opioider
DK08020810.1T DK2062573T3 (da) 2001-05-01 2002-04-30 Misbrugsresistent opioid indeholdende transdermale systemer
DK02731653T DK1397095T3 (da) 2001-05-01 2002-04-30 Misbrugsresistente, opioid-holdige transdermale systemer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10009943.1T DK2316439T3 (da) 2001-05-01 2002-04-30 Misbrugssikrede transdermale systemer, der indeholder opioider

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK02731653T DK1397095T3 (da) 2001-05-01 2002-04-30 Misbrugsresistente, opioid-holdige transdermale systemer

Country Status (11)

Country Link
US (2) US20040241218A1 (da)
EP (3) EP1397095B1 (da)
JP (3) JP5296284B2 (da)
AT (2) ATE533478T1 (da)
CY (2) CY1108821T1 (da)
DE (1) DE60230138D1 (da)
DK (3) DK2316439T3 (da)
ES (3) ES2377672T3 (da)
PT (3) PT2316439E (da)
SI (3) SI1397095T1 (da)
WO (1) WO2002087482A1 (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
AU2002339378A1 (en) 2001-05-22 2002-12-03 Euro-Celtique Compartmentalized dosage form
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
NZ535971A (en) 2002-04-23 2007-07-27 Alza Corp Transdermal analgesic patch with reduced abuse potential
EP2298302A1 (en) * 2002-06-10 2011-03-23 Euro-Celtique S.A. Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
US7815934B2 (en) * 2002-09-20 2010-10-19 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
DE10250088A1 (de) * 2002-10-25 2004-05-06 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
EP2316440A1 (en) * 2003-04-30 2011-05-04 Purdue Pharma L.P. Transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer and one fluid communication between the surface of the active agent and the adverse agent
US7182955B2 (en) * 2003-04-30 2007-02-27 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
MXPA06000990A (es) * 2003-07-25 2006-04-11 Euro Celtique Sa Tratamiento pre-operatorio del dolor post-operatorio.
CN1909892A (zh) * 2003-10-30 2007-02-07 阿尔扎公司 具有降低的滥用可能性的透皮止痛剂系统
US8535711B2 (en) 2004-01-23 2013-09-17 Teikoku Pharma Usa, Inc. Medication disposal system
US7867511B2 (en) 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
WO2005081825A2 (en) * 2004-02-23 2005-09-09 Euro-Celtique S.A. Abuse resistance opioid transdermal delivery device
EP1796651B1 (en) * 2004-08-20 2015-05-20 3M Innovative Properties Company Transdermal drug delivery device with translucent protective film
US7226619B1 (en) 2004-09-07 2007-06-05 Pharmorx Inc. Material for controlling diversion of medications
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
CA2580329C (en) 2004-09-13 2015-01-06 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery
ATE471146T1 (de) * 2004-10-21 2010-07-15 Durect Corp Transdermale verabreichungssysteme
WO2006069008A1 (en) * 2004-12-22 2006-06-29 Vesta Medical, Llc Compositions and devices for inactivation of pharmaceuticals to facilitate waste disposal, and methods thereof
US20060182819A1 (en) 2005-02-17 2006-08-17 Ough Yon D Soap scent patch and treatment for muscle spasm and pain
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential
US20060257460A1 (en) * 2005-05-13 2006-11-16 Jansen Rolf R Multilayer drug delivery system with barrier against antagonist exposure
WO2006124584A2 (en) 2005-05-13 2006-11-23 Alza Corporation Multilayer drug delivery system with barrier against reservoir material flow
US20070014839A1 (en) * 2005-07-18 2007-01-18 Stefan Bracht Decomposer film for transdermal patches
EP2308480B1 (en) 2005-09-23 2014-08-13 ALZA Corporation High Enhancer-Loading Polyacrylate Formulation for Transdermal Applications
US20070098772A1 (en) 2005-09-23 2007-05-03 Westcott Tyler D Transdermal norelgestromin delivery system
CA2629046C (en) * 2005-12-13 2014-04-08 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
DE102006025282A1 (de) * 2006-05-31 2007-12-20 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System
HUE032156T2 (en) 2006-06-19 2017-09-28 Alpharma Pharmaceuticals Llc Pharmaceutical preparations
US20080008747A1 (en) * 2006-07-07 2008-01-10 Royds Robert B Transdermal patch
KR101230804B1 (ko) 2006-07-21 2013-02-08 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 향상된 흡수를 갖는 경점막 전달 장치
US20080233156A1 (en) * 2006-10-11 2008-09-25 Alpharma, Inc. Pharmaceutical compositions
US20080286348A1 (en) * 2007-05-16 2008-11-20 Todhunter John A Secured transdermal delivery system
DE102007041557B4 (de) * 2007-08-29 2011-03-31 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend längliche Hohlkörper
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20090196890A1 (en) * 2007-12-17 2009-08-06 Alpharma Pharmaceuticals, Llc Pharmaceutical compositions
MX2010010512A (es) * 2008-03-26 2010-11-09 Alltranz Inc Formulaciones transdermicas de agonistas y antagonistas-agonistas de opiato que impiden el abuso.
DE102008016804B4 (de) 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
CA2795158C (en) * 2010-04-02 2019-10-22 Alltranz Inc. Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
JP6158810B2 (ja) 2011-08-18 2017-07-05 バイオデリバリー サイエンシズ インターナショナル，インコーポレーテッド ブプレノルフィンの乱用抵抗性粘膜付着性送達デバイス
MX352051B (es) 2011-09-30 2017-11-06 Verde Environmental Tech Inc Sistema de desecho de parche transdermico.
WO2013049387A1 (en) 2011-09-30 2013-04-04 Teikoku Pharma Usa, Inc. General medication disposal system
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
CA2962080A1 (en) 2014-09-24 2016-03-31 Pain Therapeutics, Inc. 4:3 naltrexone: 5-methyl-2-furaldehyde cocrystal
US10010543B1 (en) 2014-12-23 2018-07-03 Barr Laboratories, Inc. Transdermal dosage form
US10213586B2 (en) 2015-01-28 2019-02-26 Chrono Therapeutics Inc. Drug delivery methods and systems
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
WO2017147568A1 (en) * 2016-02-26 2017-08-31 Case Western Reserve University Composite membranes for flow batteries
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
US11389844B2 (en) 2018-03-20 2022-07-19 Verde Environmental Technologies, Inc. Blister pack disposal system
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
WO2020008366A1 (en) * 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal dosage form
WO2020009685A1 (en) * 2018-07-02 2020-01-09 John Tang Transdermal dosage form
US20210346662A1 (en) * 2018-10-23 2021-11-11 Kindeva Drug Delivery L.P. Tamper evident transdermal patch
CA3150767A1 (en) * 2019-08-12 2021-02-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Pharmaceutical compositions comprising a combination of opioid antagonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US6096756A (en) * 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US5573778A (en) * 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
AU6657396A (en) * 1995-07-28 1997-02-26 Novartis Ag Transdermal system
US7011843B2 (en) * 1997-10-01 2006-03-14 Lts Lohmann-Therapie Systeme Ag Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system
TR200001828T2 (tr) 1997-12-22 2000-11-21 Euro-Celtique, S.A. Opioid dozaj şekillerinin kötüye kullanımını önlemeye yönelik bir yöntem.
US6554851B1 (en) * 1999-05-07 2003-04-29 Scimed Life Systems, Inc. Methods of sealing an injection site
ES2487514T3 (es) * 2001-04-23 2014-08-21 Euro-Celtique S.A. Sistema de eliminación para forma de dosificación transdérmica

Also Published As

Publication number Publication date
JP2013144702A (ja) 2013-07-25
ES2546828T3 (es) 2015-09-29
DE60230138D1 (de) 2009-01-15
SI2316439T1 (sl) 2015-10-30
ATE415952T1 (de) 2008-12-15
EP2062573A1 (en) 2009-05-27
US20040241218A1 (en) 2004-12-02
US20140199383A1 (en) 2014-07-17
JP5296284B2 (ja) 2013-09-25
DK2316439T3 (da) 2015-08-10
EP1397095B1 (en) 2008-12-03
CY1112271T1 (el) 2015-12-09
ATE533478T1 (de) 2011-12-15
DK1397095T3 (da) 2009-03-09
WO2002087482A1 (en) 2002-11-07
EP1397095A4 (en) 2005-05-25
CY1108821T1 (el) 2014-04-09
EP2316439A1 (en) 2011-05-04
JP2015042649A (ja) 2015-03-05
EP1397095A1 (en) 2004-03-17
PT2062573E (pt) 2012-01-11
EP2316439B1 (en) 2015-06-17
ES2377672T3 (es) 2012-03-29
ES2318010T3 (es) 2009-05-01
JP2004529155A (ja) 2004-09-24
SI1397095T1 (sl) 2009-04-30
PT1397095E (pt) 2009-02-17
EP2062573B1 (en) 2011-11-16
SI2062573T1 (sl) 2012-02-29
PT2316439E (pt) 2015-08-28

Similar Documents

Publication Publication Date Title
DK2062573T3 (da) Misbrugsresistent opioid indeholdende transdermale systemer
EA200600696A1 (ru) Фармацевтические композиции для предотвращения передозировки или неправильного употребления лекарственных средств
DE60127277D1 (de) Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert
HK1225311A1 (zh) 透皮或透粘膜應用活性劑的用途和製劑
HUP0104709A2 (hu) Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására
BR0016826A (pt) Artigo absorvente antimicrobiano, métodos de produção e uso dos mesmos
BR9917089A (pt) Composições e métodos para distribuição mucosal
DE60118885D1 (de) Nitratsalze von antimikrobiellen wirkstoffen
DE602004019653D1 (de) Eine Missbrauch verhinderende, transdermale Dosierungsform, die einen Wirkstoff und einen Antagonisten des Wirkstoffs enthält
BR0312782A (pt) Composição para o tratamento de manchas
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE60233891D1 (de) Selektives targeting von apoptotischen zellen
SE0103276L (sv) Anordning för administrering av salva till en hudyta
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
HUP0204208A2 (hu) Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény
PT1200071E (pt) Comprimidos fracamente doseados e processo de preparacao
DE60110087D1 (de) Verwendung von Carboanhydrase-Inhibitoren zur Prävention von diabetischer Retinopathie bei Diabetikern
DK1156829T3 (da) Stabil formulering indeholdende fumagillin
EP1603595A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRUG INDEPENDENCE
IT1265647B1 (it) Composizione farmaceutiche topiche per le allergie respiratorie
CY1116853T1 (el) Διαδερμικα συστηματα οπιοειδων περισταλτικα της απροσφορης χρησης
PT1206267E (pt) Medicamentos contendo oligo-ou/e polirribonucleotidos xenogenicos
TR200400812T3 (tr) KanserÁtedavisiÁiçinÁretinoidÁreseptörÁligandlarınınÁveÁseçilenÁsitotoksikÁmaddelerinÁsinerjistikÁkombinasyonları
CY1109316T1 (el) Συνδυαστικη αγωγη για πολλαπλη σκληρυνση